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The work of a few investigators over a decade
ago described a disturbance in water and salt
metabolism in pemphigus and suggested an ad-
renal dysfunction as the basic physiopathologic
change in this disease (1—4). Pathologic findings
in the adrenal glands at necropsy, although rare,
were also quoted in suport of this view (5, 6).
Most papers referred to pemphigus vulgaris, in
the acute or chronic forms. In regard to pemphi-
gus foliaceus there was only a reference to 4 pa-
tients studied by Lever and Talbott (4) besides
the paper of one of us (T.A.F.) and Brandäo (7),
reporting that biochemical studies and post-mor-
tem observations were not conclusive as to an
etiologie role of the adrenals in this disease.
Interest in the subject was recently stimulated
since the observation of the favorable response
of pemphigus to adrenoeortieotropie and cortieoid
hormones. Progress in methods of study of ad-
renal function made possible new lines of research.
Almeida (8) perfomed the 4-hour ACTH test of
Thorn et at. (9) in 18 male and in 7 female pa-
tients with pemphigus foliaeeus and found an ab-
sence of eosinopenie response in 64% of the eases,
which he consider a sign of adrenoeortieal hypo-
function. Caeeialanza et at. (10) made the dosage
of urinary excretion of reducing eortieoids and
17-ketosteroids in 15 patients (8 with pemphigus
vulgaris, 1 with pemphigus erythematosus, 1 with
pemphigus vegetans and 5 with dermatitis her-
petiformis) finding subnormal figures in some of
the patients, with values lowest in long-standing
eases. There was no apparent difference between
pemphigus and Duhring's disease. However, a dif-
ference in response was noted after stimulation
with ACTH: in pemphigus values were low and
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even lower than those found in basal conditions,
where as in dermatitis herpetiformis the excre-
tion of the reducing eorticoids was greatly in-
creased. Quiroga and Corti (11) found 17-keto-
steroid levels consistently decreased in 8 eases of
pcmphigus vulgaris and in 4 out of 5 cases of
pemphigus foliaceus, and ascribed importance to
this dosage in the differential diagnosis of pem-
phigus with other bullous disease. Cohen et at.
(12) examined the 24-hour urinary excretion of
17-ketosteroids in S patients suffering from pem-
phigus vulgaris obtaining values between 4.7
and 12 mg, somewhat below the normal average
found in the laboratory in which the tests were
perfomed. Xavier et at. (13) found in 9 patients
with Brazilian pemphigus foliaceus (Fogo selva-
gem) 0.1 to 1.7 mg per day and in 1 patient
with pemphigus vulgaris aeutus 2.1. However,
these authors did not find any correlation be-
tween the very low figures of 17-ketosteroids and
the clinical course of the disease.
MATERIAL AND METHODS
The investigation was carried out in 21 patients
with pemphigus foliaceus hospitalized in the Der-
matologie Clinic of the Faculty of Medicine of the
University of Minas Gerais. In all eases the clin-
ical diagnosis was confirmed by histopathologieal
examinations.
The dosages of the 24-hour urinary excretion
of 17-ketosteroids were performed according to
the method of Drekter et at. (14) with slight modi-
fications suggested by Antunes (15). Normal val-
ues by this method are 10 to 20 mg for male, 5 to
15 mg for female and an average of 4 mg for chil-
dren from 7 to 12 years of age. For each patient
two dosages were used, the results showing an
average difference of 0.3 per 24 hours.
RE5ULT5
The results of the urinary excretion of 17-keto-
steroids are represented in Table I. The dosages
gave figures below the normal in 61.8 per cent of
the eases. However in most eases there were only
slight deviations from the normal. Four out of


























1. MAC 16 F 9 ms 9 10 Excellent Sulfamides 1,240 8.2
2. MNS 25 F 8 ys Present 6 Good Local 1,600 7.4
3. ZMJ 19 F 11 ys 1 Good Antimalarial drug 1,300 3.6
4. AAR 36 F 6 ms 1 56 Poor Triamcinolone 2,330 5.4
5. MLS 14 F 3 ys 10 Poor Local 1,200 3.6
6. ECE 46 F 4 ys 3 55 Good Local 2,180 7.8
7. NMG 55 F 7 ys 3 60 Fair Antimalarial drug 2,230 4.0
8. GBJ 40 F 33 ms 29 50 Good Local 1,980 5.9
9. NGL 37 F 20 ms Present 88 Fair Cortisone 1,480 1.9
10. MAJ 17 F 2 ys Present 48 Good Sulfamides 2,000 3.7
11. MEDS 16 F 4 ms Present 80 Fair Triamcinolone 1,000 3.0
12. MGT 9 F 6 ys Present 7 Fair Sulfamides 570 1.6
13. lBS 21 F 43 ms Present 5 Good Local 1,540 3.5
14. MLL 26 F 30 ms 4 28 Good Sulfamides 1,270 4.5
15. JBP 23 M 4 ys Present 20 Fair Triamcinolone 3,930 3.2
16. AMA 22 M 9 ms Present 15 Poor Local 370 4.0
17. JPR 17 M 8 ms Present 3 Poor Cortisone 1,400 8.3
18. AMR 28 M 6 ys 3 Good Local 2,700 12.6
19. VPM 25 M 10 ys 1 Good Local 1,760 13.0
20. GACV 21 M 4 ys 8 Excellent Local 1,580 11.3
21. MSM 24 F 11 ys 4 Excellent Antimalarial drug 820 3.8
five patients under steroid therapy also exhibited
subnormal values, which were not lower than
those from patients under other types of treat-
ment.
COMMENTS
All patients had the generalized form of the
disease, according to the classification of Yieira
(16), Rabello (17) and Orsini (18). In this study
there are no cases of pemphigus erythematosus,
which we consider a forme fruste of pemphigus
foliaceus.
These results did not show any correlation be-
tween the figures obtained and the cutaneous and
general conditions of the patients studied. Only
1 patient whose condition was poor had normal
excretion of 17-ketosteroids, but the status from
13 with subnormal values was fair in 5, good in
4 and excellent in 1.
It should be pointed out that, with one excep-
tion, all patients who had bullae, indicating activ-
ity of the disease process, gave low values.
It is a known fact that there is adrenal de-
pression during cortisone therapy, which is ex-
plained by Ingle and Baker (19) as a consequence
of the involution of the zona fasciculata of the
adrenal cortex by supressing the endogenous se-
cretion of ACTH. However the figures obtained
in 4 patients under cortisone therapy were not
lower than those from patients with other type
of treatment and in one patient was even normal.
The results of the present investigation are in
agreement with our previous work (7), according
to blood values of sodium and potassium.
From our present knowledge of the subject we
are not allowed to talk of an adrenal disfunction
having an etiologic role in pemphigus foliaceus.
What seems to occur in this disease as well as
in others of infectious or toxic nature, is an in-
crease in the requirements of adrenocortical hor-
mones by the organism, far in excess of the phys-
iological amounts, due to the continuous stress
represented by a chronic and serious disease like
pemphigus. The patients whose glands are un-
able to meet this daily increased demand as well
as the emergencies of the frequent recurrences,
would exhaust their reserve and show a relative
insufficiency. These patients have a functional ad-
renal hypofunction.
SUMMARY
The 24-hour urinary excretion of 17-ketoster-
oids was determined in 21 patients with clinical
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and histological diagnosis of pemphigus foliaceus.
The values were subnormal in 13 patients (61.8%)
and normal in 8 patients. There was no correla-
tion between the figures obtained and the clinical
and cutaneous course of the disease. The low
values may be explained by an inability of the
adrenal glands to meet the increased daily re-
quirements of hormones by the organism sub-
mitted to a continuous stress represented by a
chronic and serious disease like pemphigus foli-
aceus.
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